Literature DB >> 19810757

Computational investigation of the oxidative deboronation of boroglycine, H2N-CH2-B(OH)2, Using H2O and H2O2.

Joseph D Larkin1, George D Markham, Matt Milkevitch, Bernard R Brooks, Charles W Bock.   

Abstract

We report results from a computational investigation of the oxidative deboronation of boroglycine, H2N-CH2-B(OH)2, using H2O and H2O2 as the reactive oxygen species (ROS) to yield aminomethanol, H2N-CH2-OH; these results complement our study on the protodeboronation of boroglycine to produce methylamine, H2N-CH3 (Larkin et al. J. Phys. Chem. A 2007, 111, 6489-6500). Second-order Møller-Plesset (MP2) perturbation theory with Dunning-Woon correlation-consistent (cc) basis sets were used for the calculations with comparisons made to results from density functional theory (DFT) at the PBE1PBE/6-311++G(d,p)(cc-pVDZ) levels. The effects of a bulk aqueous environment were also incorporated into the calculations employing PCM and CPCM methodology. Using H2O as the ROS, the reaction H2O + H2N-CH2-B(OH)2 --> H2N-CH2-OH + H-B(OH)2 was calculated to be endothermic; the value of DeltaH(298)(0) was +12.0 kcal/mol at the MP2(FC)/cc-pVTZ computational level in vacuo and +13.7 kcal/mol in PCM aqueous media; the corresponding value for the activation barrier, DeltaH(double dagger), was +94.3 kcal/mol relative to the separated reactants in vacuo and +89.9 kcal/mol in PCM aqueous media. In contrast, the reaction H2O2 + H2N-CH2-B(OH)2 --> H2N-CH2-OH + B(OH)3 was calculated to be highly exothermic with an DeltaH(298)(0) value of -100.9 kcal/mol at the MP2(FC)/cc-pVTZ computational level in vacuo and -99.6 kcal/mol in CPCM aqueous media; the highest-energy transition state for the multistep process associated with this reaction involved the rearrangement of H2N-CH2-B(OH)(OOH) to H2N-CH2-O-B(OH)2 with a DeltaH(double dagger) value of +23.2 kcal/mol in vacuo relative to the separated reactants. These computational results for boroglycine are in accord with the experimental observations for the deboronation of the FDA approved anticancer drug bortezomib (Velcade, PS-341), where it was found to be the principle deactivation pathway (Labutti et al. Chem. Res. Toxicol. 2006, 19, 539-546).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19810757      PMCID: PMC4219543          DOI: 10.1021/jp904149w

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  36 in total

1.  Generalized Gradient Approximation Made Simple.

Authors: 
Journal:  Phys Rev Lett       Date:  1996-10-28       Impact factor: 9.161

2.  Prediction of a family of cage-shaped boric acid clusters.

Authors:  Weizhou Wang; Yu Zhang; Kaixun Huang
Journal:  J Phys Chem B       Date:  2005-05-12       Impact factor: 2.991

3.  Aminomethaneboronic acids. Synthesis and inhibition of boron analogue of esterase substrates.

Authors:  R N Lindquist; A C Nguyen
Journal:  J Am Chem Soc       Date:  1977-09-14       Impact factor: 15.419

4.  Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites.

Authors:  Teresa Pekol; J Scott Daniels; Jason Labutti; Ian Parsons; Darrell Nix; Elizabeth Baronas; Frank Hsieh; Liang-Shang Gan; Gerald Miwa
Journal:  Drug Metab Dispos       Date:  2005-03-11       Impact factor: 3.922

5.  Structure of the boronic acid dimer and the relative stabilities of its conformers.

Authors:  Joseph D Larkin; Krishna L Bhat; George D Markham; Bernard R Brooks; Henry F Schaefer; Charles W Bock
Journal:  J Phys Chem A       Date:  2006-09-14       Impact factor: 2.781

6.  Oxidative deboronation of the peptide boronic acid proteasome inhibitor bortezomib: contributions from reactive oxygen species in this novel cytochrome P450 reaction.

Authors:  Jason Labutti; Ian Parsons; Ron Huang; Gerald Miwa; Liang-Shang Gan; J Scott Daniels
Journal:  Chem Res Toxicol       Date:  2006-04       Impact factor: 3.739

7.  (1-Aminoethyl)boronic acid: a novel inhibitor for Bacillus stearothermophilus alanine racemase and Salmonella typhimurium D-alanine:D-alanine ligase (ADP-forming).

Authors:  K Duncan; W S Faraci; D S Matteson; C T Walsh
Journal:  Biochemistry       Date:  1989-04-18       Impact factor: 3.162

Review 8.  Development of the proteasome inhibitor Velcade (Bortezomib).

Authors:  Julian Adams; Michael Kauffman
Journal:  Cancer Invest       Date:  2004       Impact factor: 2.176

9.  Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids.

Authors:  J Adams; M Behnke; S Chen; A A Cruickshank; L R Dick; L Grenier; J M Klunder; Y T Ma; L Plamondon; R L Stein
Journal:  Bioorg Med Chem Lett       Date:  1998-02-17       Impact factor: 2.823

Review 10.  Recent advances in the medicinal chemistry of alpha-aminoboronic acids, amine-carboxyboranes and their derivatives.

Authors:  Valery M Dembitsky; Abed Al Aziz Quntar; Morris Srebnik
Journal:  Mini Rev Med Chem       Date:  2004-11       Impact factor: 3.862

View more
  3 in total

1.  Heats of Formation for the Boronic Acids R-B(OH)2 and Boroxines R3B3O3 (R=H, Li, HBe, H2B, H3C, H2N, HO, F, and Cl) Calculated at the G2, G3, and G4 Levels of Theory.

Authors:  Charles W Bock; Joseph D Larkin
Journal:  Comput Theor Chem       Date:  2012-04-15       Impact factor: 1.926

2.  A computational investigation of the nitrogen-boron interaction in o-(N,N-dialkylaminomethyl)arylboronate systems.

Authors:  Joseph D Larkin; John S Fossey; Tony D James; Bernard R Brooks; Charles W Bock
Journal:  J Phys Chem A       Date:  2010-11-05       Impact factor: 2.781

3.  Thermodynamics of boroxine formation from the aliphatic boronic acid monomers R-B(OH)2 (R = H, H3C, H2N, HO, and F): a computational investigation.

Authors:  Krishna L Bhat; George D Markham; Joseph D Larkin; Charles W Bock
Journal:  J Phys Chem A       Date:  2011-06-08       Impact factor: 2.781

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.